Lysine

Lysine

SCHEMBL2369399

C1CCC(NC2CCCCC2)CC1.NCCCCC(N)C(=O)O

nearest known ligand 0.62

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

PPARDPTGS1PTGS2dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Lysine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ GSR P00390 1/20 0.62
▸ CPB2 Q96IY4 5/20 0.47
▸ DPP7 Q9UHL4 6/20 0.43
▸ DPP4 P27487 4/20 0.43
▸ DPP8 Q6V1X1 3/20 0.43
▸ ITGB3 P05106 2/20 0.43
▸ ITGA2B P08514 2/20 0.43
▸ DPP9 Q86TI2 2/20 0.42
▸ FAP Q12884 1/20 0.42
▸ ARG2 P78540 4/20 0.41
▸ ARG1 P05089 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Lysine SCHEMBL2100363 1.00 GSR (0.62) GSRCPB2DPP7DPP4DPP8
Lysine SCHEMBL23728835 0.85 GSR (0.87) GSRCPB2ARG2ARG1
Lysine SCHEMBL18986644 0.85 GSR (0.87) GSRCPB2ARG2ARG1
Norleucine SCHEMBL29557418 0.84 METAP1 (0.51) DPP7DPP4DPP8DPP9FAP
Norleucine SCHEMBL14935842 0.84 METAP1 (0.51) DPP7DPP4DPP8DPP9FAP
Lysine SCHEMBL237658 0.84 GSR (0.54) GSRCPB2DPP7DPP4DPP8
Lysine SCHEMBL237659 0.84 GSR (0.54) GSRCPB2DPP7DPP4DPP8
D-Glutamate SCHEMBL27975473 0.81 GRM8 (0.60) GSRDPP7DPP4DPP8DPP9
Glutamic Acid SCHEMBL27975498 0.81 GRM8 (0.60) GSRDPP7DPP4DPP8DPP9
SCHEMBL22197609 0.79 CPB2 (0.54) GSRCPB2DPP7DPP4DPP8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3414005-A1 CRYOGEL FOR THE REMOVAL OF HEPARINS AND HEPARINOIDS FROM AQUEOUS SOLUTIONS, PHYSIOLOGICAL SOLUTIONS AND BIOLOGICAL FLUIDS, PREPARATION PROCESS AND USES THEREOF Consiglio Nazionale Delle Ricerche (IT) 2018-12-19 — — EP disclosed
WO-2017137919-A1 CRYOGEL FOR THE REMOVAL OF HEPARINS AND HEPARINOIDS FROM AQUEOUS SOLUTIONS, PHYSIOLOGICAL SOLUTIONS AND BIOLOGICAL FLUIDS, PREPARATION PROCESS AND USES THEREOF CONSIGLIO NAZIONALE DELLE RICERCHE (IT) 2017-08-17 — — WO disclosed
WO-2011109767-A2 GELATINASE INHIBITORS AND PRODRUGS UNIVERSITY OF NOTRE DAME DU LAC (US) 2011-09-09 — — WO disclosed
EP-1896135-A2 PROCESSES FOR PRODUCTION OF 4-(BIPHENYLYL)AZETIDIN-2-ONE PHOSPHONIC ACIDS Microbia, Inc. (US) 2008-03-12 — — EP disclosed
WO-2006127893-A2 PROCESSES FOR PRODUCTION OF 4-(BIPHENYLYL)AZETIDIN-2-ONE PHOSPHONIC ACIDS MICROBIA, INC. (US) 2006-11-30 — — WO disclosed
WO-2004008151-A2 NEW COMBINATORIAL PEPTIDE LIBRARIES CONTAINING MARKERS AND METHODS FOR THEIR PREPARATION AND UTILIZATION COMGENEX RT. (HU) 2004-01-22 — — WO disclosed
Send feedback